RICHMOND, Calif., Aug. 10, 2017 /PRNewswire/ -- Sangamo
Therapeutics, Inc. (Nasdaq: SGMO) announced today that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's
chief executive officer, will present at the 2017 Wedbush PacGrow
Healthcare Conference on Tuesday, August
15th at 9:45 a.m. Eastern
Time. The conference is being held in New York from August
15-16, 2017.
The presentation will be webcast live and may be accessed via a
link on the Sangamo Therapeutics website in the Investor and Media
section under Events and Presentation. The presentation will be
archived on the Sangamo website for two weeks after the event.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc.
is focused on translating ground-breaking science into genomic
therapies that transform patients' lives using the Company's
industry leading platform technologies in genome editing, gene
therapy, gene regulation and cell therapy. For more information
about Sangamo, visit www.sangamo.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-presentation-at-the-2017-wedbush-pacgrow-healthcare-conference-300502892.html
SOURCE Sangamo Therapeutics, Inc.